IP Library › Assignment 061349/0399
Patent Assignment
Reel/Frame 061349/0399

Merger and Change of Name

Recorded: 2022-10-07 Pages: 5
Assignors
LUMENA PHARMACEUTICALS LLC
Executed: 2020-06-26
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property (1)
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
Application: 17/951,326 →
Publication: US 2023/0212211
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 7, 2022
From: GEDULIN, BRONISLAVA; GREY, MICHAEL; O'DONNELL, NIALL
To: LUMENA PHARMACEUTICALS, INC.
Reel/Frame 061628/0992 →
Change of Name Oct 7, 2022
From: LUMENA PHARMACEUTICALS, INC.
To: LUMENA PHARMACEUTICALS LLC
Reel/Frame 061629/0008 →